12
Participants
Start Date
February 8, 2024
Primary Completion Date
February 29, 2028
Study Completion Date
February 29, 2028
Metreleptin
Metreleptin is a recombinant human leptin analog that is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency
RECRUITING
Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez, Lille
RECRUITING
Hopital Pitie-Salpetriere, Paris
RECRUITING
Hôpital Saint-Antoine, Paris
RECRUITING
Centre Hospitalier Lyon-Sud, Pierre-Bénite
RECRUITING
Charite-Universitaetsmedizin Berlin - Campus Charite Mitte (CCM), Berlin
NOT_YET_RECRUITING
Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin, Ulm
RECRUITING
Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi, Bologna
NOT_YET_RECRUITING
"Universitá degli Studi Magna Graecia di Catanzaro", Catanzaro
RECRUITING
Azienda Ospedaliero Universitaria Maggiore della Carità di Novara, Novara
RECRUITING
Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello, Pisa
RECRUITING
A.S.U Integrata di Udine - Presidio Ospedaliero Santa Maria della Misericordia, Udine
NOT_YET_RECRUITING
Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital, Cambridge
Lead Sponsor
Amryt Pharma
INDUSTRY